2022
DOI: 10.1055/a-1960-3198
|View full text |Cite
|
Sign up to set email alerts
|

Rapid hemostasis using a self-assembling peptide matrix for midprocedural bleeding in endoscopic sphincterotomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 5 publications
0
5
0
Order By: Relevance
“…Risk factors of post‐EST hemorrhage include coagulopathy, anticoagulation within 3 days after ERCP, cholangitis, bleeding during EST, and ERCP at institutions with low case volume 2 . Options for achieving hemostasis after post‐EST hemorrhage include compression with balloon catheters, applying ice‐cold water or saline solution with epinephrine, injection of hypertonic saline and epinephrine, coagulation with hemostatic forceps, argon plasma coagulation, clipping, placement of covered self‐expandable metal stents, and a self‐assembling peptide matrix 1,3–5 . However, some of these methods may require specialized devices or complicated procedures and involve high costs.…”
Section: Brief Explanationmentioning
confidence: 99%
“…Risk factors of post‐EST hemorrhage include coagulopathy, anticoagulation within 3 days after ERCP, cholangitis, bleeding during EST, and ERCP at institutions with low case volume 2 . Options for achieving hemostasis after post‐EST hemorrhage include compression with balloon catheters, applying ice‐cold water or saline solution with epinephrine, injection of hypertonic saline and epinephrine, coagulation with hemostatic forceps, argon plasma coagulation, clipping, placement of covered self‐expandable metal stents, and a self‐assembling peptide matrix 1,3–5 . However, some of these methods may require specialized devices or complicated procedures and involve high costs.…”
Section: Brief Explanationmentioning
confidence: 99%
“…In the GI field, numerous studies have shown that RDI is useful for the control of bleeding through improved visibility of the deep thick vessels 20 and bleeding points in hemorrhagic ulcers 21 , 22 and esophageal variceal rupture. 23 However, in the biliopancreatic area, only some case reports 24 , 25 , 26 are available and no large‐scale studies have been performed.…”
Section: Mechanisms and Equipment Of Ieementioning
confidence: 99%
“…Recently, a method for maintaining visibility during gastrointestinal bleeding involving the injection of a gel with an appropriate viscosity (Viscoclear; Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan) was reported 2 3 . Additionally, the hemostatic effect of a self-assembling peptide gel (PuraStat; 3-D Matrix Europe SAS, Lyon, France) used during gastrointestinal endoscopic procedures has been reported 4 5 . Purastat is an aqueous peptide solution that becomes neutral upon contact with blood and body fluids, and its peptide molecules form fibers in solution to form a peptide hydrogel.…”
Section: Figmentioning
confidence: 99%